188 related articles for article (PubMed ID: 8219367)
1. Capillary basement membrane in retina, kidney, and muscle of diabetic dogs and galactosemic dogs and its response to 5 years aldose reductase inhibition.
Engerman RL; Kern TS; Garment MB
J Diabetes Complications; 1993; 7(4):241-5. PubMed ID: 8219367
[TBL] [Abstract][Full Text] [Related]
2. Retinal capillaries: basement membrane thickening by galactosemia prevented with aldose reductase inhibitor.
Robison WG; Kador PF; Kinoshita JH
Science; 1983 Sep; 221(4616):1177-9. PubMed ID: 6612330
[TBL] [Abstract][Full Text] [Related]
3. Increases in collagen type IV and laminin in galactose-induced retinal capillary basement membrane thickening--prevention by an aldose reductase inhibitor.
Das A; Frank RN; Zhang NL; Samadani E
Exp Eye Res; 1990 Mar; 50(3):269-80. PubMed ID: 2108050
[TBL] [Abstract][Full Text] [Related]
4. Effects of an aldose reductase inhibitor, SNK-860, on the histopathological changes of retinal tissues in a streptozotocin-induced diabetic rat model.
Akita M; Mizuno K; Matsubara A; Nakano K; Kurono M
Acta Med Okayama; 1993 Oct; 47(5):299-304. PubMed ID: 8273453
[TBL] [Abstract][Full Text] [Related]
5. Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs.
Engerman RL; Kern TS
Diabetes; 1993 Jun; 42(6):820-5. PubMed ID: 8495805
[TBL] [Abstract][Full Text] [Related]
6. Galactose-induced retinal microangiopathy in rats.
Kern TS; Engerman RL
Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):490-6. PubMed ID: 7843917
[TBL] [Abstract][Full Text] [Related]
7. Retinal polyol and myo-inositol in galactosemic dogs given an aldose-reductase inhibitor.
Kern TS; Engerman RL
Invest Ophthalmol Vis Sci; 1991 Dec; 32(13):3175-7. PubMed ID: 1748548
[TBL] [Abstract][Full Text] [Related]
8. Aldose reductase activity and basement membrane thickening.
Frank RN
Metabolism; 1986 Apr; 35(4 Suppl 1):35-40. PubMed ID: 3083207
[TBL] [Abstract][Full Text] [Related]
9. Discordant effects of the aldose reductase inhibitor, sorbinil, on vascular structure and function in chronically diabetic and galactosemic rats.
Tilton RG; Pugliese G; LaRose LS; Faller AM; Chang K; Province MA; Williamson JR
J Diabet Complications; 1991; 5(4):230-7. PubMed ID: 1779018
[TBL] [Abstract][Full Text] [Related]
10. Aldose reductase and the development of renal disease in diabetic dogs.
Kern TS; Engerman RL
J Diabetes Complications; 1999; 13(1):10-6. PubMed ID: 10232704
[TBL] [Abstract][Full Text] [Related]
11. [Prevention of pericyte ghost formation in retinal capillaries by aldose reductase inhibitor in galactose-fed dogs with diabetic retinopathy].
Akagi Y; Terubayashi H; Ikebe H; Kador PF; Kinoshita JH
Nippon Ganka Gakkai Zasshi; 1988 Sep; 92(9):1479-84. PubMed ID: 3145681
[No Abstract] [Full Text] [Related]
12. Prevention or moderation of some ultrastructural changes in the RPE and retina of galactosemic rats by aldose reductase inhibition.
Vinores SA; Campochiaro PA
Exp Eye Res; 1989 Sep; 49(3):495-510. PubMed ID: 2507341
[TBL] [Abstract][Full Text] [Related]
13. Correlation between erythrocyte aldose reductase activity and the width of skeletal-muscle capillary basement membrane in insulin-dependent diabetes mellitus.
Hamada Y; Hammon K; Raskin P
J Diabetes Complications; 1992; 6(4):242-6. PubMed ID: 1482782
[TBL] [Abstract][Full Text] [Related]
14. Prevention of pericyte ghost formation in retinal capillaries of galactose-fed dogs by aldose reductase inhibitors.
Kador PF; Akagi Y; Terubayashi H; Wyman M; Kinoshita JH
Arch Ophthalmol; 1988 Aug; 106(8):1099-102. PubMed ID: 3401138
[TBL] [Abstract][Full Text] [Related]
15. Pathogenetic heterogeneity in retinal capillary basement membrane thickening in the diabetic BB-rat.
Chakrabarti S; Sima AA
Diabetologia; 1987 Dec; 30(12):966-8. PubMed ID: 3125081
[TBL] [Abstract][Full Text] [Related]
16. Prevention of diabetes-related retinal microangiopathy with aldose reductase inhibitors.
Robison WG
Adv Exp Med Biol; 1988; 246():365-72. PubMed ID: 3150650
[TBL] [Abstract][Full Text] [Related]
17. The effect of myo-inositol treatment on basement membrane thickening in the BB/W-rat retina.
Chakrabarti S; Sima AA
Diabetes Res Clin Pract; 1992 Apr; 16(1):13-7. PubMed ID: 1576927
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructural localization of blood-retinal barrier breakdown in diabetic and galactosemic rats.
Vinores SA; McGehee R; Lee A; Gadegbeku C; Campochiaro PA
J Histochem Cytochem; 1990 Sep; 38(9):1341-52. PubMed ID: 2117624
[TBL] [Abstract][Full Text] [Related]
19. Permeability changes in blood-retinal barrier of galactosemic rats are prevented by aldose reductase inhibitors.
Lightman S; Rechthand E; Terubayashi H; Palestine A; Rapoport S; Kador P
Diabetes; 1987 Nov; 36(11):1271-5. PubMed ID: 3117606
[TBL] [Abstract][Full Text] [Related]
20. Sorbinil does not prevent galactose-induced glomerular capillary basement membrane thickening in the rat.
Das A; Frank RN; Zhang NL
Diabetologia; 1990 Sep; 33(9):515-21. PubMed ID: 2123806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
